d16:0

DL-erythro/threo Sphinganine (d16:0) is a sphingolipid that is decreased in rats following long-term, low-dose administration of dimethoate and is used as a biomarker for dimethoate exposure. It has been found in the fermentation broth of Bacterium SRCnm, which has antimicrobial and antioxidant activities. This product is a mixture of sphinganine (d16:0), L-erythro sphinganine (d16:0), D-threo sphinganine (d16:0), and L-threo sphinganine (d16:0).

Sphinganine (d16:0 branched), an aniso-branched sphingolipid, is identified as a constituent of ceramide-containing phospholipids in bacteria.

C16 Ceramide (d16:1,C16:0) is a bioactive sphingolipid that induces the formation and thermal stabilization of ordered phases and gel phases enriched in palmitoyl sphingomyelin domains within palmitoyl phosphatidylcholine (POPC) bilayers. It is found in human erythrocyte sphingomyelin.

Enrofloxacin (BAY-Vp2674) is a veterinary antibacterial agent, used in poultry.

7-Methoxy-4(1H)-quinazolinone ,with CAS No. 16064-24-7, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 7-Methoxy-4(1H)-quinazolinone provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

SR-4995 (CID 16016685) is a highly efficient and selective ABHD5 ligand that directly binds to ABHD5 and induces lipolysis by releasing it from PLIN, activating HSL and PLIN1 through PKA-dependent phosphorylation.

neuropeptide Y1 receptor antagonist

PD 160336 is a biochemical.

CID 16020046 (C390-0219) is a selective GPR55 antagonist, inhibiting GPR55 constitutive activity with IC50 of 0.15 μM in yeast.

Enrofloxacin-d5 is a deuterium marker for Enrofloxacin and can be used in isotope tracer experiments.Enrofloxacin (BAY-Vp2674) is an antibiotic that acts against Mycoplasma bovis and has a MIC90 of 0.312 μg/mL.

Enrofloxacin-OVA is a hapten-carrier protein conjugate formed by coupling Enrofloxacin to chicken ovalbumin (OVA). As a hapten, Enrofloxacin alone cannot induce an immune response and must be conjugated to a large molecular protein to become a complete antigen with immunogenicity.Enrofloxacin-OVA may be supplied as a lyophilized powder or as a solution. The solution is prepared in 0.01 M TBS (pH 7.4) buffer at a typical concentration of 1 mg/mL.

Enrofloxacin-BSA is a hapten-carrier protein conjugate formed by coupling Enrofloxacin to bovine serum albumin (BSA). As a hapten, Enrofloxacin alone cannot induce an immune response and must be conjugated to a large molecular protein to become a complete antigen with immunogenicity. Enrofloxacin-BSA may be supplied as a lyophilized powder or as a solution. The solution is prepared in 0.01 M TBS (pH 7.4) buffer at a typical concentration of 1 mg/mL.